Evidence map›Paper›PMID 21208652›Full record

ArticleThe Journal of allergy and clinical immunology2011

Specificity protein 1 is pivotal in the skin's antiviral response.

Lianghua Bin, Michael D Howell, Byung Eui Kim, Joanne E Streib, Clifton F Hall, Donald Y M Leung

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Microbiology spectrum · 2023
    Article
  3. Sp1-mediated miR-193b suppresses atopic dermatitis by regulating HMGB1.The Kaohsiung journal of medical sciences · 2023
    Article
  4. Epigenetic Mechanisms of Epidermal Differentiation.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Innate Antiviral Immunity in the Skin.Trends in immunology · 2018
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Staphylococcus aureus α-toxin modulates skin host response to viral infection.The Journal of allergy and clinical immunology · 2012
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lianghua BinDepartment of Pediatrics, National Jewish Health, Denver, Colo, USA.
Michael D Howell
Byung Eui Kim
Joanne E Streib
Clifton F Hall
Donald Y M Leung
University of Colorado Denver · USNational Jewish Health · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
Atopic Dermatitis and Vaccinia Immunization Network Clinical ConsortiumN01AI40029 · NIAID · NATIONAL JEWISH HEALTH · 2008 to 2010
$8.6M
Statistical and Data Coordinating Center for the ADVNN01AI40033 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI ATHEY, CAROL · 2008 to 2014
$6.2M
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASER01AR041256 · NIAMS · NATIONAL JEWISH HEALTH · PI GOLEVA, ELENA, LEUNG, DONALD YM · 1992 to 2020
$5.9M
ATOPIC DERMITITIS VACCINIA NETWORK /ADVN/-266040029N01AI040029 · NIAID · NATIONAL JEWISH MEDICAL AND RESEARCH CEN · PI LEUNG, DONALD YM · 2006 to 2006
–
NCRR NIH HHS 1 UL1 RR025780NCRR NIH HHS UL1 RR025780NIAID NIH HHS N01 AI040029NIAID NIH HHS N01 AI040033NIAID NIH HHS N01 AI 40029NIAID NIH HHS N01 AI40033NIAID NIH HHS U01 AI147462NIAMS NIH HHS AR41256NIAMS NIH HHS R01 AR041256
6 · The paper itself

Abstract

backgroundPrevious studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells.

objectivesWe investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH(+)).

methodsSmall interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study.

resultsBoth VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = -0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-γ augmented the antiviral capacity of Sp1-silenced keratinocytes.

conclusionSpecificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH(+) patients may contribute to their increased propensity to disseminated skin viral infections. IFN-γ augmentation may be a potential treatment for ADEH(+) patients.

Indexed as

2',5'-Oligoadenylate SynthetaseAdultCells, CulturedDermatitis, AtopiceIF-2 KinaseEukaryotic Initiation Factor-2FemaleGene SilencingHumansInterferon-gammaKaposi Varicelliform EruptionKeratinocytesMaleMiddle AgedSkinSp1 Transcription Factor2',5'-Oligoadenylate SynthetaseeIF-2 KinaseEukaryotic Initiation Factor-2Interferon-gammaSp1 Transcription Factor

Identifiers

PMID21208652
PMCPMC3734863
OpenAlexW2121653558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.